66. IgA nephropathy Clinical trials / Disease details
Clinical trials : 255 / Drugs : 255 - (DrugBank : 79) / Drug target genes : 35 - Drug target pathways : 137
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | EUCTR2007-000443-99-DE (EUCTR) | 09/04/2008 | 13/11/2008 | Comparison of the sequential maintenance therapy with Mycophenolat and Prednisolon to standard therapy after completed induction therapy – a multicenter, randomised, phase III intervention study for progressive IgA-Nephritis | Comparison of the sequential maintenance therapy with Mycophenolat and Prednisolon to standard therapy after completed induction therapy – a multicenter, randomised, phase III intervention study for progressive IgA-Nephritis | progressive IgA-Nephritis MedDRA version: 9.1;Level: LLT;Classification code 10029143;Term: Nephritis-glomerular | Trade Name: Myfortic INN or Proposed INN: Mycophenolat-Natrium Trade Name: Decortin H INN or Proposed INN: Prednisolon | Universitätsklinikum Ulm | NULL | Not Recruiting | Female: yes Male: yes | Phase 3 | Germany |